THE ROLE OF POLYMORPHIC VARIANTS OF NO-SYNTHASE, RECEPTOR ENDOTHELIN-1 AND NADPH-OXIDASE IN THE DEVELOPMENT OF HEART FAILURE RESULTED FROM CHEMOTHERAPY-INDUCED CARDIOTOXICITY